Совместимость Дексазон и Диаглинид®
Страница описания препарата Дексазон
Страница описания препарата Диаглинид®
Cтепень серьёзности/тяжести
Достоверность
Описание взаимодействия
Источники
Печатные издания
Alternate day corticosteroid causes alternate day hyperglycaemia
Postgrad Med J /Volume:63 Part:743/Sep Page:761-4 / 1987 / Greenstone MA, Shaw AB
Disorder of glucose metabolism regulation in patients with multiple myeloma treated with high doses of corticosteroids at our clinic in 2004
Vnitr Lek /Volume:53 Part:1/Jan Page:18-23 / 2007 / Pospísilová Y, Adam Z
Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities
Acta Diabetol /Volume:46 Part:2/Jun Page:85-95 / 2009 / Resmini E, Minuto F, Colao A et al
Hyperglycemic consequences of corticosteroid premedication in an outpatient population
AJR Am J Roentgenol /Volume:194 Part:6/Jun Page:W483-8 / 2010 / Davenport MS, Cohan RH, Caoili EM et al
Hyperglycemia after repeated periocular dexamethasone injections in patients with diabetes
Ophthalmology /Volume:113 Part:10/Oct Page:1720-3 / 2006 / Feldman-Billard S, Du Pasquier-Fediaevsky L, Héron E
Cтепень серьёзности/тяжести
Достоверность
Описание взаимодействия
Источники
Печатные издания
Influence of drugs interacting with CYP3A4 on the pharmacokinetics, pharmacodynamics, and safety of the prandial glucose regulator repaglinide
J Clin Pharmacol /Volume:43 Part:6/Jun Page:649-60 / 2003 / Hatorp V, Hansen KT, Thomsen MS
Drug-drug and food-drug pharmacokinetic interactions with new insulinotropic agents repaglinide and nateglinide
Clin Pharmacokinet /Volume:46 Part:2 Page:93-108 / 2007 / Scheen AJ
Drug interactions of clinical importance with antihyperglycaemic agents: an update
Drug Saf /Volume:28 Part:7 Page:601-31 / 2005 / Scheen AJ
Effect of rifampicin on the pharmacokinetics and pharmacodynamics of nateglinide in healthy subjects
Br J Clin Pharmacol /Volume:56 Part:4/Oct Page:427-32 / 2003 / Niemi M, Backman JT, Neuvonen M et al
Rifampin decreases the plasma concentrations and effects of repaglinide
Clin Pharmacol Ther /Volume:68 Part:5/Nov Page:495-500 / 2000 / Niemi M, Backman JT, Neuvonen M et al